[{"Assets_0_Q2_USD":335987000.0,"CommonStockSharesOutstanding_0_Q2_shares":32275000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":128345000.0,"NetIncomeLoss_1_Q2_USD":10594000.0,"NetIncomeLoss_2_Q2_USD":114833000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":35272000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":34884000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":32082000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":31858000.0,"StockholdersEquity_0_Q2_USD":317222000.0,"EarningsPerShareBasic_1_Q2_USD":0.33,"EarningsPerShareBasic_2_Q2_USD":3.6,"EarningsPerShareDiluted_1_Q2_USD":0.3,"EarningsPerShareDiluted_2_Q2_USD":3.29,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":40031000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":172422000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]